WeightWatchers CEO Sima Sistani talks TikTok, Telehealth Deal on GLP-1/Ozempic and Why She Took the Job

WeightWatchers CEO Sima Sistani talks TikTok,...

Up next

Rep. Ro Khanna on Epstein, ICE & a Billionaire Wealth Tax

Democratic California Representative Ro Khanna joins Kara for a wide-ranging conversation about the culture of impunity that’s taken hold in America during President Trump’s second term. They discuss Khanna's visit to an immigration detention facility, the Trump administration’s ...  Show more

Imran Ahmed Researches Online Hate. Trump Wants to Deport Him

As the founder and CEO of the Center for Countering Digital Hate, Imran Ahmed specializes in researching how hate and disinformation spread online. His work has made him a target of Elon Musk and the Trump administration — he’s one of five European tech regulators and researchers ...  Show more

Recommended Episodes

The Big Business Behind Weight Loss Drugs
Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

WeightWatchers CEO Explains Why ‘We Got It Wrong’
Chasing Life

Long before WeightWatchers became a weight loss empire, the legacy dieting company started as a small support group in the 1960s. The company rose to popularity preaching a message of moderation and making healthy choices. But in what some call a surprising pivot, WeightWatchers ...  Show more

Is Ozempic Really A Weight Loss Wonder Drug?
The Quicky

You may have heard about a new miracle weight loss drug called Ozempic. Videos have been spreading online of users claiming insane weight loss in short periods of time. Even celebrities like Kim Kardashian have been accused of using it to slim down. There's just one problem...Oze ...  Show more

Those New Obesity Drugs Really Work–If You Can Afford Them
Big Take

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more